THE PATHOLOGY OF FAMILIAL BREAST CANCER: PREDICTIVE VALUE OF IMMUNOHISTOCHEMICAL MARKERS ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, HER-2, AND P53 IN PATIENTS WITH MUTATIONS IN BRCA1 AND BRCA2

LAKHANI, S.R., VIJVER, M.J., & JACQUEMIER, J.. (2002). THE PATHOLOGY OF FAMILIAL BREAST CANCER: PREDICTIVE VALUE OF IMMUNOHISTOCHEMICAL MARKERS ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, HER-2, AND P53 IN PATIENTS WITH MUTATIONS IN BRCA1 AND BRCA2. JOURNAL OF CLINICAL ONCOLOGY, 20(9), 2310-2318. SID. https://sid.ir/paper/630420/en

LAKHANI S.R., VIJVER M.J., JACQUEMIER J.. THE PATHOLOGY OF FAMILIAL BREAST CANCER: PREDICTIVE VALUE OF IMMUNOHISTOCHEMICAL MARKERS ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, HER-2, AND P53 IN PATIENTS WITH MUTATIONS IN BRCA1 AND BRCA2. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2002;20(9):2310-2318. Available from: https://sid.ir/paper/630420/en

S.R. LAKHANI, M.J. VIJVER, and J. JACQUEMIER, “THE PATHOLOGY OF FAMILIAL BREAST CANCER: PREDICTIVE VALUE OF IMMUNOHISTOCHEMICAL MARKERS ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, HER-2, AND P53 IN PATIENTS WITH MUTATIONS IN BRCA1 AND BRCA2,” JOURNAL OF CLINICAL ONCOLOGY, vol. 20, no. 9, pp. 2310–2318, 2002, [Online]. Available: https://sid.ir/paper/630420/en